WASHINGTON (AP) — The Food and Drug Administration says it approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by Genentech.
The diagnostic test is the first approved to detect genetic mutations found in roughly 10 percent of patients with the most prevalent form of lung cancer, known as non-small cell lung cancer.
Patients who test positive for the mutation are more likely to respond to Genentech's drug Tarceva as a first-choice treatment, and the FDA expanded the drug's approval for that use in an announcement Tuesday. The drug was previously approved only as a second-line option after patients had failed to respond to chemotherapy.
Lung cancer is the deadliest form of cancer among both men and women in the U.S.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Three Republican lawmakers are calling on the state Department of Natural Resources to cancel the four-day antlerless deer hunt in northern Wisconsin scheduled to begin Thursday because of a depleted herd.
The holiday season has come to life in Downtown Neenah!
Packers defensive tackle Ryan Pickett might hit hard on the field, but he's got a soft spot for helping out during the holidays.
As people mourn the passing of Nelson Mandela around the world in Northeast Wisconsin, it's no different.
Two off-duty Sheboygan police officers were arrested Wednesday night for drunken driving.
St. Nicholas Day is Friday, and the night before, many stockings are hung by the mantle, or in some cultural traditions, shoes will be put out, waiting for a visit from St. Nick.